EC Number |
Inhibitors |
Structure |
---|
3.4.22.53 | alpha2-Macroglobulin |
0.05 mg/ml, 11% inhibition |
|
3.4.22.53 | antipain |
0.01 mM, 80-90% inhibition |
|
3.4.22.53 | antipain |
0.01 mM 56% inhibition |
|
3.4.22.53 | antipain |
0.02 mM, 82% loss of activity |
|
3.4.22.53 | antipain |
0.02 mM, 87% loss of activity |
|
3.4.22.53 | antipain |
- |
|
3.4.22.53 | antipain |
0.05 mM, complete inhibition |
|
3.4.22.53 | benzyloxycarbonyl-L-leucyl-L-leucinal |
- |
|
3.4.22.53 | benzyloxycarbonyl-Leu-Abu-CONH-CH2-C6H3(3,5-(OMe)2) |
calpain-2 selective inhibitor. A selective calpain-2 inhibitor could prevent acute glaucoma-induced retinal ganglion cell death and blindness |
|
3.4.22.53 | benzyloxycarbonyl-Leu-Leu-leucinal |
- |
|